Alphabet’s Verily and Novartis eye-care subsidiary Alcon are pulling the plug on the glucose monitoring “smart lens” device the two companies had been attempting to build since 2014, according to a post by Verily chief technical officer Brian Otis on the company’s website Friday.
It’s Lights Out For Novartis And Verily’s Glucose Monitoring ‘Smart Lens’ Project
